Onconova Therapeutics (ONTX) Tops Q3 EPS by 6c

Onconova Therapeutics (NASDAQ: ONTX) reported Q3 EPS of ($0.23), $0.06 better than the analyst estimate of ($0.29). Revenue for the quarter came in at $60 thousand versus the consensus estimate of $69.25 thousand.

For earnings history and earnings-related data on Onconova Therapeutics (ONTX) click here.

You May Also Be Interested In

• Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics
• BMO starts chip stocks coverage: Here are its preferred picks
• The Buckle (BKE) Tops Q2 EPS by 7c, Beats on Revenue